The DU145 human prostate carcinoma cell line harbors a temperature-sensitive allele of p53
- PMID: 16741917
- DOI: 10.1002/pros.20462
The DU145 human prostate carcinoma cell line harbors a temperature-sensitive allele of p53
Abstract
Background: Some nuances of mutant and wild-type p53 activity have been uncovered utilizing temperature sensitive (TS) alleles. However, few human tumor derived cell lines possess a TS p53 mutant.
Methods: The cell lines DU145 (heterozygous p53, P223L, and V274F) and PC3 (p53-null, where exogenous P223L and V274F were introduced individually or in combination) were examined for TS p53 activity as revealed by reporter construct and target gene activation.
Results: TS p53 function was observed in DU145 and expression of the P223L allele in PC3 conferred a TS p53 profile. Activation of p21Waf1 demonstrated that P223L TS activity may have been influenced by cellular context.
Conclusions: The DU145 cell line harbors a TS mutant of p53 and, in addition to being a widely used model of human prostate carcinoma, may also reveal new insights into p53 function due to the unique transcriptional properties of its TS phenotype.
Similar articles
-
Cooperation of two mutant p53 alleles contributes to Fas resistance of prostate carcinoma cells.Cancer Res. 2003 Jun 1;63(11):2905-12. Cancer Res. 2003. PMID: 12782597
-
Wild-type p53 suppresses growth of human prostate cancer cells containing mutant p53 alleles.Cancer Res. 1991 Sep 1;51(17):4716-20. Cancer Res. 1991. PMID: 1873816
-
PC3, but not DU145, human prostate cancer cells retain the coregulators required for tumor suppressor ability of androgen receptor.Prostate. 2006 Sep 1;66(12):1329-38. doi: 10.1002/pros.20483. Prostate. 2006. PMID: 16835890
-
Transcription regulation by mutant p53.Oncogene. 2007 Apr 2;26(15):2202-11. doi: 10.1038/sj.onc.1210294. Oncogene. 2007. PMID: 17401429 Review.
-
Assessing p53 in clinical contexts: unlearned lessons and new perspectives.J Pathol. 2006 Jan;208(1):1-6. doi: 10.1002/path.1913. J Pathol. 2006. PMID: 16331594 Review.
Cited by
-
AURKA suppression induces DU145 apoptosis and sensitizes DU145 to docetaxel treatment.Am J Transl Res. 2013 Apr 19;5(3):359-67. Print 2013. Am J Transl Res. 2013. PMID: 23634246 Free PMC article.
-
Intracellular CD24 disrupts the ARF-NPM interaction and enables mutational and viral oncogene-mediated p53 inactivation.Nat Commun. 2015 Jan 20;6:5909. doi: 10.1038/ncomms6909. Nat Commun. 2015. PMID: 25600590 Free PMC article.
-
Pin1 Inhibitor Juglone Exerts Anti-Oncogenic Effects on LNCaP and DU145 Cells despite the Patterns of Gene Regulation by Pin1 Differing between These Cell Lines.PLoS One. 2015 Jun 3;10(6):e0127467. doi: 10.1371/journal.pone.0127467. eCollection 2015. PLoS One. 2015. PMID: 26039047 Free PMC article.
-
Chaperoning of mutant p53 protein by wild-type p53 protein causes hypoxic tumor regression.J Biol Chem. 2012 Jan 20;287(4):2907-14. doi: 10.1074/jbc.M111.317354. Epub 2011 Dec 6. J Biol Chem. 2012. PMID: 22147694 Free PMC article.
-
Traditional Herbal Formula Taeeumjowi-Tang (TJ001) Inhibits p53-Mutant Prostate Cancer Cells Growth by Activating AMPK-Dependent Pathway.Evid Based Complement Alternat Med. 2019 May 5;2019:2460353. doi: 10.1155/2019/2460353. eCollection 2019. Evid Based Complement Alternat Med. 2019. PMID: 31191706 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous